Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Emmanuelle Bourbouloux"'
Autor:
Paule Augereau, Anne Patsouris, Emmanuelle Bourbouloux, Carole Gourmelon, Sophie Abadie Lacourtoisie, Dominique Berton Rigaud, Patrick Soulié, Jean Sebastien Frenel, Mario Campone
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
Endocrine therapy is the mainstay of treatment of estrogen-receptor-positive (ER+) breast cancer with an overall survival benefit. However, some adaptive mechanisms in the tumor emerge leading to the development of a resistance to this therapy. A bet
Externí odkaz:
https://doaj.org/article/ca4c0958e557434eae385369c0c3ecc5
Autor:
Nassima Redjimi, Karine Duperrier-Amouriaux, Isabelle Raimbaud, Immanuel Luescher, Danijel Dojcinovic, Jean-Marc Classe, Dominique Berton-Rigaud, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, Danila Valmori, Maha Ayyoub
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e22845 (2011)
Spontaneous CD4(+) T-cell responses to the tumor-specific antigen NY-ESO-1 (ESO) are frequently found in patients with epithelial ovarian cancer (EOC). If these responses are of effector or/and Treg type, however, has remained unclear. Here, we have
Externí odkaz:
https://doaj.org/article/72191bbdfda1414c9260fa0ce840fd80
Autor:
Camille Moreau-Bachelard, Marie Robert, Carole Gourmelon, Emmanuelle Bourbouloux, Anne Patsouris, Jean-Sébastien Frenel, Mario Campone
Publikováno v:
Expert Opinion on Pharmacotherapy. :1-7
Autor:
Olivier Colomban, Emmanuelle Bourbouloux, Marie-Ange Mouret-Renier, Domenica Lorusso, Cyriac Blonz, Aude Marie Savoye, Gilles Freyer, Margot Noblecourt, Michel Gatineau, Laëtitia Stefani, Laurence Gladieff, Florence Joly, Laurence Venat-Bouvet, Delphine Mollon-Grange, Ulla Peen, Lucia Borgato, Eric Pujade-Lauraine, Benoit You, Claire Falandry
Publikováno v:
Ovarian cancer.
Autor:
Marie Lange, Sophie Lefevre Arbogast, Isabelle Hardy-Léger, Olivier Rigal, Johan Le Fel, Barbara Pistilli, Jean Petrucci, Christelle Lévy, Aurélie Capel, Charles Coutant, Laure Médeau, Florence Lerebours, Laurence Vanlemmens, Marine Brion, Emmanuelle Bourbouloux, Maxime Blain, Giulia Binarelli, Ines Vaz-Luis, Bénédicte Giffard, Ophélie Querel, Sibille Everhard, Fabrice André, Cécile Charles, Sarah Dauchy, Florence Joly
Publikováno v:
Journal of the National Cancer Institute.
BackgroundUsing the large nationwide French, national, multicenter, prospective cancer and toxicities (CANTO) cohort, we assessed cognitive functioning change after cancer treatments in a subgroup of breast cancer (BC) patients.MethodsWe included pat
Autor:
Audrey Petit, Bertrand Porro, Emmanuelle Bourbouloux, Yves Roquelaure, Philippe Colombat, Jean-Baptiste Fassier, Magalie Le-Blanc Onfroy
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2021, ⟨10.1016/j.bulcan.2021.06.016⟩
Bulletin du Cancer, 2021, ⟨10.1016/j.bulcan.2021.06.016⟩
Resume Introduction Le sentiment d’efficacite personnelle a retourner au travail est un determinant psychologique majeur du retour au travail de patients diagnostiques d’un cancer. Cependant, les investigations francaises dans ce domaine ne prenn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea87d3b74746b54b26e3f8c6a5038a2
https://hal.science/hal-03477334
https://hal.science/hal-03477334
Autor:
Frédérique Rousseau, Olivier Tredan, E. Malaurie, Aude-Marie Savoye, Pierre-Emmanuel Brachet, Claire Falandry, Jørn Herrstedt, Robert Sverdlin, Laurence Venat-Bouvet, Eric Pujade-Lauraine, Emmanuelle Bourbouloux, Alain Lortholary, Fabien Tinquaut, Loic Mourey, Gilles Freyer, Véronique D'Hondt, Marie-Ange Mouret-Reynier, Laetitia Stefani, Alain Zannetti, Domenica Lorusso
Publikováno v:
Falandry, C, Rousseau, F, Mouret-Reynier, M A, Tinquaut, F, Lorusso, D, Herrstedt, J, Savoye, A M, Stefani, L, Bourbouloux, E, Sverdlin, R, D'Hondt, V, Lortholary, A, Brachet, P E, Zannetti, A, Malaurie, E, Venat-Bouvet, L, Trédan, O, Mourey, L, Pujade-Lauraine, E & Freyer, G 2021, ' Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin plus Paclitaxel for Vulnerable Older Adult Women with Ovarian Cancer : A GINECO/GCIG Randomized Clinical Trial ', JAMA Oncology, vol. 7, no. 6, pp. 853-861 . https://doi.org/10.1001/jamaoncol.2021.0696
JAMA oncology
JAMA oncology, American Medical Association, 2021, 7 (6), pp.853-861. ⟨10.1001/jamaoncol.2021.0696⟩
JAMA oncology
JAMA oncology, American Medical Association, 2021, 7 (6), pp.853-861. ⟨10.1001/jamaoncol.2021.0696⟩
Importance: Single-agent carboplatin is often proposed instead of a conventional carboplatin-paclitaxel doublet in vulnerable older patients with ovarian cancer. Such an approach could have a detrimental effect on outcomes for these patients. Objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6434fefd1cc9c7262154fcb13014cf
https://portal.findresearcher.sdu.dk/da/publications/18f3b090-9904-4260-8677-da31b5d2d220
https://portal.findresearcher.sdu.dk/da/publications/18f3b090-9904-4260-8677-da31b5d2d220
Autor:
Carole Gourmelon, Dominique Berton Rigaud, Emmanuelle Bourbouloux, Anne Patsouris, Mario Campone, Paule Augereau, Marie Robert, Jean-Sebastien Frenel
Publikováno v:
Expert Review of Anticancer Therapy. 20:85-95
Introduction: Pertuzumab, a humanized monoclonal antibody that binds the human epidermal growth factor receptor 2 (HER2), inhibits the heterodimerization of HER2 with other HER receptors. It has been approved both by the Food and Drug Administration
Autor:
Dominique Berton Rigaud, Emmanuelle Bourbouloux, Anne Patsouris, Mario Campone, Paule Augereau, Jean-Sebastien Frenel, Carole Gourmelon, Marie Robert
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 15:85-91
INTRODUCTION The combination of cyclin-dependent kinases 4 and 6 (CDK 4 and 6) inhibitors with endocrine therapy represents a new standard of care for endocrine-receptor positive metastatic breast cancer. Currently, three compounds are approved. Abem
Autor:
Jean Petrucci, Charles Coutant, F Andre, Sibille Everhard, F. Joly Lobbedez, Laurence Vanlemmens, J. Le Fel, Florence Lerebours, Emmanuelle Bourbouloux, Aurélie Capel, A-L. Martin, Marie Lange, Olivier Rigal, C. Levy, Cécile Charles, Barbara Pistilli, Ines Vaz-Luis, Sarah Dauchy, Isabelle Hardy-Léger, S. Lefevre Arbogast
Publikováno v:
Annals of Oncology. 32:S412-S413